Senseonics (NYSE:SENS) Shares Down 12.2% - Time to Sell?

Key Points

• Senseonics Holdings, Inc. stock fell 12.2% on Tuesday, trading as low as $7.33 after closing at $8.47, with trading volume increasing significantly.
• Analysts have mixed opinions on the stock; Barclays and HC Wainwright have set target prices of $30.00 and $28.00 respectively, while Stifel Nicolaus issued a target of $9.00.
• Currently, only 12.36% of the stock is held by institutional investors, which may indicate potential for increased ownership and market stability.

Shares of Senseonics Holdings, Inc. (NYSE:SENS - Get Free Report) fell 12.2% during mid-day trading on Tuesday . The stock traded as low as $7.33 and last traded at $7.44. 889,546 shares changed hands during trading, an increase of 115% from the average session volume of 412,836 shares. The stock had previously closed at $8.47.

Wall Street Analyst Weigh In

Several research firms recently issued reports on SENS. Barclays began coverage on Senseonics in a research report on Wednesday, August 27th. They set an "overweight" rating and a $30.00 price target on the stock. HC Wainwright restated a "buy" rating and issued a $28.00 price objective (up previously from $22.00) on shares of Senseonics in a report on Tuesday, July 8th. Stifel Nicolaus assumed coverage on Senseonics in a report on Tuesday. They issued a "hold" rating and a $9.00 price objective for the company. Lake Street Capital upgraded Senseonics to a "strong-buy" rating in a report on Thursday, July 17th. Finally, TD Cowen assumed coverage on Senseonics in a report on Tuesday, July 15th. They issued a "buy" rating and a $25.00 price objective for the company. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, Senseonics has an average rating of "Buy" and a consensus target price of $26.40.

Senseonics Stock Performance

The firm has a fifty day moving average price of $9.07 and a 200 day moving average price of $10.42. The firm has a market capitalization of $6.16 billion, a PE ratio of -58.15 and a beta of 0.83. The company has a debt-to-equity ratio of 59.17, a current ratio of 2.47 and a quick ratio of 2.38.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. CTC Alternative Strategies Ltd. acquired a new position in shares of Senseonics during the 1st quarter valued at about $31,000. IFP Advisors Inc lifted its position in shares of Senseonics by 120.9% in the 1st quarter. IFP Advisors Inc now owns 47,500 shares of the company's stock worth $31,000 after acquiring an additional 26,000 shares during the period. Smith Salley Wealth Management bought a new stake in shares of Senseonics in the 1st quarter worth approximately $36,000. State of Wyoming bought a new stake in shares of Senseonics in the 1st quarter worth approximately $40,000. Finally, Elite Life Management LLC bought a new stake in shares of Senseonics in the 2nd quarter worth approximately $36,000. 12.36% of the stock is owned by institutional investors and hedge funds.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.